Literature DB >> 22130629

Clinical correlations and prognostic relevance of tissue angiogenic factors in patients with gastric cancer.

Y Mohri1, C Miki, K Tanaka, A Kawamoto, M Ohi, T Yokoe, M Kusunoki.   

Abstract

AIMS: To evaluate the relationship between vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) levels in gastric cancer tissue and clinicopathological features and to determine whether these factors were correlated with survival.
MATERIALS AND METHODS: We analysed tissue samples from 58 patients with gastric cancer and used 24 normal gastric mucosae as controls. Tissue levels of VEGF and HGF were measured in tissue extracts by enzyme-linked immunosorbent assay.
RESULTS: HGF and VEGF levels were significantly higher in gastric cancer tissue than in matched normal gastric mucosa. VEGF levels were significantly increased in cancer tissue from cases involving lymphatic invasion. HGF levels were significantly increased according to the disease stage. Patients with high levels of VEGF or HGF showed significantly worse survival rates than patients with low levels. Using multivariate analysis, a high level of VEGF or HGF was an independent factor predicting poor survival.
CONCLUSIONS: Intratumoral levels of HGF and VEGF are an important prognostic determinant in gastric cancer. The current findings suggest that high concentrations of HGF and VEGF may induce aggressive tumour growth and metastasis.
Copyright © 2011 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22130629     DOI: 10.1016/j.clon.2011.11.002

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN: 0936-6555            Impact factor:   4.126


  4 in total

1.  Clinical significance of various growth factors in patients with different gastric neoplasms.

Authors:  Lidia Kędzierska; Anna Madej-Michniewicz; Natalia Marczuk; Barbara Dołęgowska; Teresa Starzyńska; Wojciech Błogowski
Journal:  Am J Transl Res       Date:  2020-01-15       Impact factor: 4.060

2.  Distinct Clinicopathological Features and Prognosis of Helicobacter pylori Negative Gastric Cancer.

Authors:  Kun-Feng Tsai; Jyh-Ming Liou; Mei-Jyh Chen; Chien-Chuan Chen; Sung-Hsin Kuo; I-Rue Lai; Kun-Huei Yeh; Ming-Tsan Lin; Hsiu-Po Wang; Ann-Lii Cheng; Jaw-Town Lin; Chia-Tung Shun; Ming-Shiang Wu
Journal:  PLoS One       Date:  2017-02-02       Impact factor: 3.240

3.  Exosomes serve as nanoparticles to suppress tumor growth and angiogenesis in gastric cancer by delivering hepatocyte growth factor siRNA.

Authors:  Haiyang Zhang; Yi Wang; Ming Bai; Junyi Wang; Kegan Zhu; Rui Liu; Shaohua Ge; JiaLu Li; Tao Ning; Ting Deng; Qian Fan; Hongli Li; Wu Sun; Guoguang Ying; Yi Ba
Journal:  Cancer Sci       Date:  2018-02-11       Impact factor: 6.716

4.  Loss of gastric gland mucin-specific O-glycan is associated with progression of differentiated-type adenocarcinoma of the stomach.

Authors:  Kazuo Shiratsu; Kayoko Higuchi; Jun Nakayama
Journal:  Cancer Sci       Date:  2013-11-22       Impact factor: 6.716

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.